Fig. 1From: Artemisinin-naphthoquine plus lower-dose primaquine to treat and prevent recurrence of Plasmodium vivax malaria: an open-label randomized and non-inferiority trialSample size calculation, enrolment, and outcomes. All the patients received directly observed treatment which varied according to the scheduled days of each regimenBack to article page